CRBP
Corbus Pharmaceuticals Holding
7.70$
-1.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -3.2% | +2.5% | +31.8% | +0.0% | -27.0% | +10,613.7% | -99.4% | – | – | +0.0% | +2.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.6% | -17.5% | +19.1% | +57.4% | -18.7% | +78.0% | -2.9% | +37.4% | -11.8% | +7.7% | +57.3% | – | |
| – | +6.3% | +23.6% | +6.8% | +13.9% | -18.7% | +8.3% | -4.1% | -10.3% | +0.1% | +26.0% | +11.8% | – | |
| – | +4.9% | -3.3% | +12.1% | +43.7% | -19.6% | -66.8% | +361.0% | +28.2% | -10.0% | +10.4% | +49.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.4% | -75.0% | +268.3% | -41.6% | +73.7% | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | +100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.